Aegerion Pharmaceuticals Inc. (AEGR): Broadfin Capital Raises Its Stake Ahead of Merger

Page 8 of 10

Page 8 of 10 – SEC Filing
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
September 12, 2016
(Date)
BROADFIN CAPITAL, LLC
By:
/s/ Kevin Kotler
Kevin Kotler, Managing Member
KEVIN KOTLER
/s/ Kevin Kotler
BROADFIN HEALTHCARE MASTER FUND, LTD.
By:
/s/ Kevin Kotler
Kevin Kotler, Director
Attention:  Intentional misstatements or omissions of fact constitute Federal criminal violations (see 18 U.S.C. 1001).

Follow Aegerion Pharmaceuticals Inc. (NASDAQ:AEGR)

Page 8 of 10